CHELMSFORD, Mass., Oct. 7, 2021 /PRNewswire/ -- Brooks
Automation, Inc. (Nasdaq: BRKS) announced today that Dr.
Amy Liao, President of Life Sciences
Services, will be transitioning into the role of strategic advisor
to the CEO until the end of this calendar year, at which time she
will leave the Company to pursue other interests.
During this transition, Dr. Liao will be advising on the Company's
growth initiatives and continued promotion of the newly formed
standalone life sciences business, Azenta Life
Sciences.
"Over the past three years since acquiring GENEWIZ, Amy has
provided superior oversight of our full integration of GENEWIZ into
Brooks, has led three years of high growth in our services
business, and has played a key role in preparing the launch of
Azenta, our fully integrated, standalone life sciences company,"
commented Steve Schwartz, President
and CEO. "As much as we will miss Amy and her strong contributions
to our leadership team, she has cemented her legacy into the future
Azenta company with the genomics capabilities being a cornerstone
of value in our company, and we are grateful she remained to see us
through the transformation of Brooks to Azenta Life Sciences."
Dr. Liao has had a long and distinguished career in genomics
services and sciences, with many academic and business achievements
to date. In 2020, in honoring an individual for a lifetime
commitment and important contributions to patient healthcare, Dr.
Liao received the coveted Biomedical Engineering Society's
Wallace A. Coulter award for
innovation in healthcare. One decade earlier, Dr. Liao along
with Dr. Steve Sun, co-founder of
GENEWIZ, received the Ernst & Young Entrepreneur Of The Year®
2010 Award in the Services category for New Jersey. Dr. Liao
was also recognized as one of NJBIZ's Best Fifty Women in Business
in 2018.
About Brooks Automation
Brooks (Nasdaq: BRKS) operates
two global, market-leading businesses, Life Sciences and
Semiconductor Solutions, each with its own distinct area of focus
and expertise. The Life Sciences business, to be operated under the
new Azenta brand, provides a full suite of reliable cold-chain
sample management solutions and genomic services across areas such
as drug development, clinical research and advanced cell therapies
for the industry's top pharmaceutical, biotech, academic and
healthcare institutions globally. On September 20, 2021, the Company announced the
pending sale to Thomas H. Lee Partners of its Semiconductor
Solutions Group business, which provides industry-leading precision
vacuum robotics, integrated automation systems and contamination
control solutions to the world's leading semiconductor chip makers
and equipment manufacturers as well as collaborative robotics and
automation capabilities for multi-market applications.
Brooks is headquartered in Chelmsford, MA, with operations
in North America, Europe and Asia. For more
information, visit www.brooks.com. For insights to the
new Azenta Life Sciences, visit www.azenta.com.
BROOKS INVESTOR CONTACTS:
Sara Silverman
Director of Investor Relations
Brooks Automation
978.262.2635
sara.silverman@brooks.com
Sherry Dinsmore
Brooks Automation
978.262.4301
sherry.dinsmore@brooks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/brooks-automation-announces-transition-and-departure-plans-of-dr-amy-liao-301395633.html
SOURCE Brooks Automation